Evidence map›Paper›PMID 39392426›Full record

ReviewDermatology practical & conceptual2024

Review - Expert Opinion on Antibiotics and Antibiotic Resistance in Dermatology.

Giuseppe Argenziano, Marco Ardigò, Giuseppe Micali, Maria Rita Nasca, Alessandra Scilletta, Linda Tognetti, Pietro Rubegni, Stefano Veraldi

Abstract readReview
In one paragraph

Review in Dermatology practical & conceptual, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Giuseppe ArgenzianoClinica Dermatologica, Università della Campania L. Vanvitelli, Napoli.
Marco ArdigòDermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Giuseppe MicaliClinica Dermatologica, Università di Catania, Catania.
Maria Rita NascaClinica Dermatologica, Università di Catania, Catania.
Alessandra ScillettaClinica Dermatologica, Università di Catania, Catania.
Linda TognettiU.O.C. Dermatologia, Dipartimento Scienze Mediche, Chirurgiche e neuroscienze, Università degli studi di Siena, Siena.
Pietro RubegniU.O.C. Dermatologia, Dipartimento Scienze Mediche, Chirurgiche e neuroscienze, Università degli studi di Siena, Siena.
Stefano VeraldiCorso di Clinica Dermatologica, Università di Milano Bicocca e Ospedale San Raffaele, Milano.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAntibiotic resistance has become a serious, severe problem worldwide. This issue does not only relate to the use of systemic antibiotics but to topical ones as well, like systemic therapies and local treatment of skin and mucosal infections. Antiseptics, an alternative to the topical treatment with antibiotics of wounds and some inflammatory dermatological conditions, tend to be microbicidal and have a broader spectrum of antimicrobial activity than antibiotics. Among these, polyhexanide (PHMB) allows for the control of the infection while avoiding the development of resistance.

objectivesRecommendations on the rules of good clinical practice for the management of small wounds, burns and post-traumatic ulcerative wounds, impetigo or folliculitis in the initial stages, and acne.

methodsLiterature review on the principal topical therapies for small wounds, injuries, impetigo, folliculitis, and acne and a proposal of innovative, highly-tolerated treatments. RESULTS AND

conclusionsGiven the abuse of topical antibiotics in dermatology, for the treatment of small wounds, injuries, localized folliculitis, impetigo, and acne, the use of alternative topical treatments like polyhexanide and Rigenase® is recommended.

Identifiers

PMID39392426
PMCPMC11620216

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.